With a new presidential administration in Washington and state lawmakers working their way through their legislative sessions ...
Accenture Chief Executive Officer (CEO) Julie Sweet has disclosed a health update in an internal mail to employees. The CEO has been diagnosed with early-stage breast cancer, with treatment expected ...
Hosted on MSN19d
Accenture CEO Julie Sweet’s cancer diagnosis shows how execs should share life-altering health eventsPlus: All the news and watercooler chat from Fortune. Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the ...
Hosted on MSN26d
Accenture CEO Julie Sweet sells $3.47 million in sharesJulie Spellman Sweet, Chair and CEO of Accenture plc (NYSE:ACN), recently sold a significant portion of her holdings in the company. According to a regulatory filing, Sweet disposed of 7,793 Class ...
Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis from my doctor is excellent; the cancer was caught ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback